GH · Company research
Guardant Health, Inc. (GH): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
26records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? | FXH is a passively managed healthcare ETF launched in 2007 with $1.13 billion in assets. It tracks the StrataQuant Health Care Index with a 0.61% expense ratio and 0.56% dividend yield. The fund has gained 16.87% year-to-date and 20.02% over the past year, with a medium risk profile (beta 0.72). It holds 74 healthcare companies with top holdings including Natera, Guardant Health, and Universal Health Services. FXH received a Zacks ETF Rank of 3 (Hold). | View source ↗ | Zacks Investment Research | Oct 19, 2026 | bullish | 0.333 | 1 |
| Guardant Health Inc (GH) Stock Down 4.4% but Still Overvalued -- GF Score: 66/100 - GuruFocus | Guardant Health Inc (GH) Stock Down 4.4% but Still Overvalued -- GF Score: 66/100 GuruFocus | View source ↗ | GuruFocus | Oct 16, 2026 | neutral | 0 | 0.6 |
| Director Tariq Musa proposes selling 116 Guardant Health (GH) shares. - Stock Titan | Director Tariq Musa proposes selling 116 Guardant Health (GH) shares. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| A colon cancer blood test had 99% screening follow-through at two rural clinics - Stock Titan | A colon cancer blood test had 99% screening follow-through at two rural clinics Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar | Zacks highlights two medical stocks with positive Earnings Surprise Prediction (ESP) figures that could beat upcoming earnings expectations. Danaher (DHR) has a +0.30% ESP with a #2 Buy rating ahead of October 21 earnings, while Guardant Health (GH) has a +13.19% ESP with a #2 Buy rating before November 5 earnings. Both stocks show potential for positive earnings surprises based on recent analyst revisions. | View source ↗ | Zacks Investment Research | Oct 15, 2026 | bullish | 1 | 1 |
| These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar | Zacks highlights two medical stocks with positive Earnings Surprise Prediction (ESP) figures that could beat upcoming earnings expectations. Danaher (DHR) has a +0.30% ESP with a #2 Buy rating ahead of October 21 earnings, while Guardant Health (GH) has a +13.19% ESP with a #2 Buy rating before November 5 earnings. Both stocks show potential for positive earnings surprises based on recent analyst revisions. | View source ↗ | Zacks Investment Research | Oct 15, 2026 | bullish | 1 | 1 |
| A director proposes selling 69 Guardant Health (GH) shares valued at $11,032. - Stock Titan | A director proposes selling 69 Guardant Health (GH) shares valued at $11,032. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Guardant Health, Inc. (GH) stock price, news, quote and history - Yahoo Finance Singapore | Guardant Health, Inc. (GH) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 9, 2026 | neutral | 0 | 0.6 |
| Grail (GRAL) vs Guardant Health (GH): Which is a Better Stock to Buy? - Yahoo Finance | Grail (GRAL) vs Guardant Health (GH): Which is a Better Stock to Buy? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| A blood test in Europe can help identify who may benefit from AstraZeneca’s breast cancer drug - Stock Titan | A blood test in Europe can help identify who may benefit from AstraZeneca’s breast cancer drug Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Guardant Health, Inc. (GH) Stock forecasts - Yahoo Finance Singapore | Guardant Health, Inc. (GH) Stock forecasts Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 8, 2026 | neutral | 0 | 0.6 |
| Guardant Health, Inc. (GH) Stock Forecasts - Yahoo Finance | Guardant Health, Inc. (GH) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 7, 2026 | neutral | 0 | 0.6 |
| A blood test found signs of melanoma returning a median 70.5 days before clinical detection - Stock Titan | A blood test found signs of melanoma returning a median 70.5 days before clinical detection Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| Guardant Health (GH) Stock Could Be Undervalued Despite Its 5x Run - Simply Wall Street | Guardant Health (GH) Stock Could Be Undervalued Despite Its 5x Run Simply Wall Street | View source ↗ | Simply Wall Street | Sep 26, 2026 | neutral | 0 | 0.6 |
| Guardant Health (GH) Rides Liquid Biopsy Growth Narrative With Valuation Still In Focus - Simply Wall Street | Guardant Health (GH) Rides Liquid Biopsy Growth Narrative With Valuation Still In Focus Simply Wall Street | View source ↗ | Simply Wall Street | Sep 25, 2026 | neutral | 0 | 0.6 |
| AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why. - Investor's Business Daily | AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why. Investor's Business Daily | View source ↗ | Investor's Business Daily | Sep 21, 2026 | neutral | 0 | 0.6 |
| 1 Unpopular Stock That Should Get More Attention and 2 We Question - StockStory | 1 Unpopular Stock That Should Get More Attention and 2 We Question StockStory | View source ↗ | StockStory | Sep 20, 2026 | neutral | 0 | 0.6 |
| Guardant Health (GH) Stock Could Trade At A 21% Discount Despite Patent Appeal - Yahoo Finance | Guardant Health (GH) Stock Could Trade At A 21% Discount Despite Patent Appeal Yahoo Finance | View source ↗ | Yahoo Finance | Aug 27, 2026 | neutral | 0 | 0.6 |
| Guardant’s New Hires Receive Stock Units in Annual Thirds - Stock Titan | Guardant’s New Hires Receive Stock Units in Annual Thirds Stock Titan | View source ↗ | Stock Titan | Aug 10, 2026 | neutral | 0 | 0.6 |
| Guardant Health Falls as Recent Rally Appears to Cool - Quiver Quantitative | Guardant Health Falls as Recent Rally Appears to Cool Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 20, 2026 | neutral | 0 | 0.6 |
| Guardant Health (GH) Stock May Look Fully Valued Following Shield Coverage News - Yahoo Finance | Guardant Health (GH) Stock May Look Fully Valued Following Shield Coverage News Yahoo Finance | View source ↗ | Yahoo Finance | Jul 3, 2026 | neutral | 0 | 0.6 |
| GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection? - Yahoo Finance | GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 1, 2026 | neutral | 0 | 0.6 |
| GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection? - Stocktwits | GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection? Stocktwits | View source ↗ | Stocktwits | Jul 1, 2026 | neutral | 0 | 0.6 |
| Guardant Health Stock Surges 19%, With A 5-Day Winning Spree - Trefis | Guardant Health Stock Surges 19%, With A 5-Day Winning Spree Trefis | View source ↗ | Trefis | Jun 30, 2026 | neutral | 0 | 0.6 |
| Why Are Guardant Health (GH) Shares Soaring Today - StockStory | Why Are Guardant Health (GH) Shares Soaring Today StockStory | View source ↗ | StockStory | Jun 26, 2026 | neutral | 0 | 0.6 |
| Why Guardant Health (GH) Stock Is Down Today - Yahoo Finance | Why Guardant Health (GH) Stock Is Down Today Yahoo Finance | View source ↗ | Yahoo Finance | May 19, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.